Greenbrook TMS, Inc. (GBNH)
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States.
Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services.
As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts.
Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
|Industry||Medical Care Facilities|
890 Yonge Street
Toronto, ON M4W 3P4
|Phone||416 621 4642|
|Fiscal Year||January - December|
|Reporting Currency||US Dollars|
|William P. Leonard||President, Chief Executive Officer and Director|
|Erns Loubser C.A., C.F.A.||Chief Financial Officer and Treasurer|
|Diana Shi||Senior Vice President of Operations|
|Euphia Hsu Smith||Chief Marketing Officer|
|Benjamin Klein||Chief Executive Officer|
|Glen Akselrod||Investor Relations Officer|
|Iris Krug||Vice President of Compliance and Privacy Officer|
|Brittany Schwemmer||Vice President of Human Resources|
|Dr. Geoffrey Grammer M.D.||Chief Medical Officer|
Latest SEC Filings
|Aug 2, 2022||6-K||Report of foreign issuer|
|Jul 28, 2022||D||Notice of Exempt Offering of Securities|
|Jul 28, 2022||6-K||Report of foreign issuer|
|Jul 27, 2022||SC 13D||General statement of acquisition of beneficial ownership|
|Jul 25, 2022||SC 13G||Statement of acquisition of beneficial ownership by individuals|
|Jul 22, 2022||6-K||Report of foreign issuer|
|Jul 14, 2022||6-K||Report of foreign issuer|
|Jun 27, 2022||6-K||Report of foreign issuer|
|Jun 22, 2022||6-K||Report of foreign issuer|
|Jun 1, 2022||6-K||Report of foreign issuer|